國際醫學研究碩博士學位學程

Medicine & Life Sciences

1. 2-dimethylamino-N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)acetamide 13%
2. Apoptosis 54%
3. Atrial Fibrillation 20%
4. Autophagy 41%
5. Biomarkers 27%
6. Blood Platelets 24%
7. Breast Neoplasms 28%
8. Calcium 21%
9. Carcinogenesis 13%
10. Carcinoma 14%
11. Cardiac Myocytes 19%
12. Catenins 26%
13. Cell Death 14%
14. Cell Line 13%
15. Cell Movement 19%
16. Cell Proliferation 18%
17. Chronic Renal Insufficiency 37%
18. Cohort Studies 26%
19. Collagen 14%
20. Colorectal Neoplasms 30%
21. Confidence Intervals 36%
22. Connective Tissue Growth Factor 16%
23. Databases 18%
24. Datasets 12%
25. Dementia 17%
26. Diabetes Mellitus 14%
27. Down-Regulation 26%
28. Drug Therapy 19%
29. Endothelial Cells 16%
30. Epithelial-Mesenchymal Transition 21%
31. ErbB Receptors 20%
32. Fibroblasts 19%
33. Fibrosis 13%
34. Gene Expression 18%
35. Genes 28%
36. Glioblastoma 31%
37. Glioma 25%
38. Growth 21%
39. Hepatocellular Carcinoma 22%
40. Histone Deacetylases 17%
41. Homeostasis 20%
42. honokiol 18%
43. In Vitro Techniques 23%
44. Inflammation 14%
45. JNK Mitogen-Activated Protein Kinases 13%
46. Kidney 23%
47. Lipopolysaccharides 13%
48. Lung 19%
49. Lung Neoplasms 29%
50. Medicine 18%
51. Messenger RNA 16%
52. Meta-Analysis 45%
53. Methylation 14%
54. MicroRNAs 13%
55. Mortality 16%
56. Mouth Neoplasms 14%
57. Nanoparticles 17%
58. National Health Programs 13%
59. Neoplasm Metastasis 34%
60. Neoplasms 58%
61. Neoplastic Stem Cells 24%
62. Non-Small Cell Lung Carcinoma 21%
63. Odds Ratio 26%
64. Ovarian Neoplasms 17%
65. Oxidative Stress 18%
66. Paclitaxel 14%
67. Parkinson Disease 21%
68. Pharmaceutical Preparations 15%
69. Phosphorylation 20%
70. Phosphotransferases 15%
71. Platelet Activation 23%
72. Platelet Aggregation 12%
73. Population 32%
74. Prostatic Neoplasms 14%
75. Proteins 43%
76. Pulmonary Veins 27%
77. Randomized Controlled Trials 12%
78. Reactive Oxygen Species 22%
79. Recurrence 13%
80. Renal Dialysis 13%
81. Retrospective Studies 13%
82. Salivary Gland Calculi 13%
83. Serum 25%
84. Sinoatrial Node 16%
85. Small Interfering RNA 13%
86. Squamous Cell Carcinoma 13%
87. Stroke 70%
88. Survival 19%
89. Systematic Reviews 29%
90. Taiwan 100%
91. Temozolomide 14%
92. Therapeutics 37%
93. Thrombin 12%
94. Thrombosis 14%
95. Toxocara canis 13%
96. Traumatic Brain Injury 16%
97. Triple Negative Breast Neoplasms 29%
98. Type 2 Diabetes Mellitus 13%
99. Up-Regulation 25%
100. Wounds and Injuries 19%